Your browser doesn't support javascript.
loading
Durvalumab After Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: The Phase 2 PACIFIC-6 Trial.
Garassino, Marina C; Mazieres, Julien; Reck, Martin; Chouaid, Christos; Bischoff, Helge; Reinmuth, Niels; Cove-Smith, Laura; Mansy, Talal; Cortinovis, Diego; Migliorino, Maria R; Delmonte, Angelo; Sánchez, José Garcia; Chara Velarde, Luis Enrique; Bernabe, Reyes; Paz-Ares, Luis; Perez, Ignacio Diaz; Trunova, Nataliya; Foroutanpour, Kayhan; Faivre-Finn, Corinne.
Afiliação
  • Garassino MC; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Hematology/Oncology, The University of Chicago, Chicago, Illinois. Electronic address: mgarassino@medicine.bsd.uchicago.edu.
  • Mazieres J; Centre Hospitalier Universitaire, Université Paul Sabatier, Toulouse, France.
  • Reck M; Lung Clinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany.
  • Chouaid C; Service de Pneumologie, Centre Hospitalier Intercommunal de Créteil, Créteil, France.
  • Bischoff H; Thoraxklinik Heidelberg, Heidelberg, Germany.
  • Reinmuth N; Asklepios Fachkliniken München-Gauting, German Center for Lung Research, Gauting, Germany.
  • Cove-Smith L; The Christie NHS Foundation Trust and Manchester University Hospitals Foundation Trust, Manchester, United Kingdom.
  • Mansy T; South Tees Hospitals NHS Foundation Trust, Middlesbrough, United Kingdom.
  • Cortinovis D; Oncology Unit, ASST-Monza, San Gerardo Hospital, Monza, Italy.
  • Migliorino MR; San Camillo-Forlanini Hospital, Rome, Italy.
  • Delmonte A; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori," Meldola, Italy.
  • Sánchez JG; Medical Oncology Department, Hospital Arnau de Vilanova, Fundación para el Fomento de la Investigación Sanitaria i Biomédica de la Comunidad Valenciana (FISABIO), Valencia, Spain.
  • Chara Velarde LE; Hospital Universitario de Guadalajara, Guadalajara, Spain.
  • Bernabe R; Hospital Universitario Virgen del Rocio, Seville, Spain.
  • Paz-Ares L; Universidad Complutense, CiberOnc, CNIO and Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Perez ID; AstraZeneca, Gaithersburg, Maryland.
  • Trunova N; AstraZeneca, Gaithersburg, Maryland.
  • Foroutanpour K; AstraZeneca, Gaithersburg, Maryland.
  • Faivre-Finn C; The University of Manchester and The Christie NHS Foundation Trust, Manchester, United Kingdom.
J Thorac Oncol ; 17(12): 1415-1427, 2022 12.
Article em En | MEDLINE | ID: mdl-35961520
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article